UC Davis Neurosurgeons Perform New Stem Cell Therapy in Cervical Spine

Researchers at UC Davis Health System have now begun to use new stem cell therapy from Mesoblast technology to promote bone tissue growth after the removal of cervical discs, according to a hospital news release.

Advertisement

Kee Kim, MD, and Rudolph Shrot, MD, are associate professors of neurosurgery at UC Davis who have performed the procedure. The surgery uses bone marrow-derived adult stem cells to promote bone tissue growth as part of a nationwide, multicenter clinical trial of the therapy.

The first procedure in the trial at UC Davis was recently performed in an anterior cervical discectomy. The stem cells were derived from a donor’s bone marrow and grown in culture to a high concentration.

Related Articles on Spine Surgery:

What Factors Into the Employment Decision for Spine Surgeons? 6 Responses

Dr. John Caruso: Becoming a Champion of Change in Healthcare

Scoliosis as a Neurologic Condition: 4 Points on Two New Genes Making the Connection

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spine

Advertisement

Comments are closed.